Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Codiak BioSciences Stock

Q: Can you buy Codiak BioSciences stock?

You can no longer buy Codiak BioSciencesstock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

codiakbio.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $168.37MM

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need.

Learn more about Codiak BioSciences IPO

Enterprise Value

Access valuation and stock price for companies like Codiak BioSciences before its IPO.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Codiak BioSciences stock FAQs

Can you buy Codiak BioSciences stock?

You can no longer buy Codiak BioSciences stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Codiak BioSciences stock?

To invest in a private company like Codiak BioSciences through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Codiak BioSciences stock?

You can no longer sell stock of Codiak BioSciences on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Codiak BioSciences stock?

If you hold private company shares of Codiak BioSciences - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Codiak BioSciences stock on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is Codiak BioSciences a public company?

No, Codiak BioSciences is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Codiak BioSciences’ stock price?

The stock price of Codiak BioSciences is $0.057 as of 4/4/23.

What is Codiak BioSciences’ stock ticker symbol?

The ticker symbol of Codiak BioSciences is CDAK.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Team

Management Team

Douglas E. Williams, Ph.D.

President, Chief Executive Officer & Board Member

Linda C. Bain

Chief Financial Officer

Richard Brudnick

Chief Business Officer & Head of Strategy

Andrea Difabio

Chief Legal Officer

Board Members

Theo Melas-Kyriazi

Jonathan Poole

Eric S. Lander, Ph.D.

Karen Bernstein, Ph.D.

Steven Gillis, Ph.D.

Charles L. Cooney, Ph.D.

Briggs W. Morrison, M.D.

Douglas E. Williams, Ph.D.

Geekwire 01/04/2019

Jazz, Codiak to Partner on Exosome Therapeutics for Cancer in $1B+ Collaboration

Jazz Pharmaceuticals will use Codiak BioSciences’ engEx™ precision engineering platform to research, develop and commercialize exosome therapeutics for cancer through a collaboration that could generate more than $1 billion for Codiak,

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.